Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 29, 2020
Europital has announced an expansion as it launches new capabilities across project management, clinical monitoring, biostatistics, pharmacovigilance, regulatory affairs and data management, in addition to its existing services of Medical Affairs and...
read more
Evecxia has expanded its previous license agreement with Duke University to include exclusive, world-wide rights to develop and commercialize methods of improving the bioavailability of 5-HTP.
read more
Thursday, September 21, 2023
A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive ...
read more
Friday, September 22, 2023
The drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive ...
read more
In light of the fast-paced healthcare digital revolution, Oxford Global’s 15th Annual Pharmaceutical IT Congress, is bursting with information on best practice, key challenges, opportunities and new tools and systems.
read more
Tuesday, November 07, 2023
Everest Clinical Research, a comprehensive contract research organization (CRO), has announced its acquisition of August Research. Everest, backed by Arlington Capital Partners, a private equity firm based in Washington, D.C. specializing in ...
read more
Monday, December 05, 2022
Founded in 2002, Brightech specializes in complex, value-add biostatistics, programming and clinical data management services. Similar to Everest, Brightech has earned a highly-regarded reputation as a critical partner for some of the world’s largest...
read more
Wednesday, September 30, 2020
Evergreen Theragnostics celebrated the groundbreaking for its new manufacturing facility in Springfield, New Jersey.
read more
EVERSANA announced a partnership with Amazon Web Services (AWS) to accelerate generative artificial intelligence (AI) use cases across the life sciences industry.
read more
Eversana™ announced the appointment of Brigham Hyde, Ph.D. to President, Data & Analytics (D&A).
read more
Tuesday, January 27, 2026
Evestia Clinical announced the acquisition of ICRC-Weyer GmbH, a Berlin-based, long-established CRO and scientific consultancy. The acquisition strengthens Evestia Clinical's presence in Germany and Europe and further enhances the company's full-...
read more
Evestia Clinical, the new identity of EMAS Pharma, has launched as a provider of clinical research in oncology and rare diseases globally.
read more
Brigham and Women’s Innovation Hub (iHub) and Evidation Health have announced a collaboration to measure the real life impact of digital health solutions on clinical and economic outcomes.
read more
Evidation Health announced it has closed a $10 million funding round led by Sanofi-Genzyme BioVentures, the corporate venture capital arm of Sanofi.
read more
Evidera, a business unit of Pharmaceutical Product Development, LLC (PPD), has entered into an exclusive collaboration agreement with Clinical Study Support, Inc. (CSS), a subsidiary of Shin Nippon Biomedical Laboratories Ltd. (SNBL), extending both ...
read more